NovaGo Therapeutics AG

NovaGo Therapeutics is a biotech start-up company dedicated to the development of human antibody therapeutics targeting cerebral stroke and spinal cord injury to stimulate nerve repair and regeneration. A strategic partnership with Neurimmune provides access to a unique class of human-derived antibodies with exceptional therapeutic properties generated through their Reverse Translational Medicine™ (RTM™) technology platform.

The founding and management team has a proven track record in research and drug development. Existing collaborations and networks with partners in industry, academia, and the medical community leverage the advancement of our programs.